Columbia University AL Amyloidosis Recent Advances In The Diagnosis & Treatment 2024

30 $

+ Include: 7 videos + 11 pdfs, size: 2 GB

+ Target Audience: pathologists, cardiologists, nephrologists

Description

+ Include: 7 videos + 11 pdfs, size: 2 GB

+ Target Audience: pathologists, cardiologists, nephrologists, immunologists, oncologists

+ Sample video: contact me for sample video

+ Information:

Columbia University Irving Medical Center invites you to join the leading educators from Columbia University, addressing an overview of high yield challenging scenarios in the management of AL Amyloidosis. Through a combination of lectures and case-based presentations, this course will deliver up-to-date and cutting-edge information that can be directly integrated into clinical practice.

Learning Objectives
-Clinical presentation, diagnostic methods and risk stratification of patients with newly diagnosed systemic AL Amyloidosis.
-Management of patients with newly diagnosed systemic AL Amyloidosis.
-Management of various organ involvement such as heart failure and nephrotic syndrome, autonomic neuropathy and GI involvement in patients with AL Amyloidosis.
-Discuss and develop consensus in guidelines for managing relapsed and refractory cases, including the role of salvage therapies and experimental approaches.

This event is designed for a diverse group of healthcare professionals involved in the diagnosis and treatment of AL amyloidosis. The target audience includes:

Physicians
Nurse Practitioners
Physician Assistants
Nurses
Pharmacists
Allied Healthcare Professionals

This course aims to provide up-to-date and cutting-edge information that can be directly integrated into clinical practice through a combination of lectures and case-based presentation.

 

+ Topics:

 

Reviews

There are no reviews yet.

Be the first to review “Columbia University AL Amyloidosis Recent Advances In The Diagnosis & Treatment 2024”

Your email address will not be published. Required fields are marked *